Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02445417 · ClinicalTrials.gov registry record
Brain Activity During Birth for Prediction of Newborns at Risk for Brain Injury
A clinical trial, sponsored by Sharp HealthCare.
- Completed
- Registry status
- 60
- Enrollment target
NCT02445417: Completed study, sponsored by Sharp HealthCare.
NCT02445417 is a clinical trial that has completed, run by Sharp HealthCare. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02445417 has completed, sponsored by Sharp HealthCare.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is early identification of asphyxiated newborns through eeg starting in the delivery room.
Primary Outcome
May be up to 60 minutes if applicable
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2015-06-25 |
What the finished NCT02445417 record still lists
NCT02445417 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02445417 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02445417 about?
NCT02445417 is a clinical study titled "Brain Activity During Birth for Prediction of Newborns at Risk for Brain Injury". The purpose of this study is early identification of asphyxiated newborns through eeg starting in the delivery room.
What is the current status of trial NCT02445417?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2015-06-25.
Who is sponsoring clinical trial NCT02445417?
This trial is sponsored by Sharp HealthCare, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI